PEMETREXED DISODIUM
| Brand name | PEMETREXED |
|---|---|
| Active ingredient | PEMETREXED DISODIUM |
| Strength | EQ 1GM/100ML BASE (10MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | May 2023 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11147817 | March 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.